Photo: academy.eahad.org
May 1, 2026, 13:23
Key Advances Across the Full Spectrum of VWD at EAHAD 2025
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A century of progress in von Willebrand Disease continues to shape how we diagnose, understand, and treat patients today.
At EAHAD 2025, this session featured Carlo Castaman, Omid Seidizadeh, and Jeroen Eikenboom to explore key advances across the full spectrum of VWD.
Missed the live session? Relive the insights anytime on EAHAD Academy.”
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared this post on LinkedIn, adding:
”It was my pleasure to be invited to contribute to this EAHAD session on von Willebrand Disease.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy
-
Jun 26, 2026, 15:51Heghine Khachatryan: Willebrand Disease – Similar Bleeding Phenotype, Distinct Pathophysiology
-
Jun 26, 2026, 15:37Von Willebrand Disease: New Diagnostic Approaches
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing